Company intelligence / Profile preview

Dermofarm

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Dermofarm develops and markets a range of dermatology and gynecology products under several brands. Their portfolio includes skin treatments for hyperpigmentation and personal care items. The company emphasizes innovation, sustainability, and high-quality standards but does not publish clinical trial results typical for biotech drug development companies.

No clinical-stage pipeline in the sense used by biotech/pharma R&D firms.

Products like hydroquinone creams are used for temporary bleaching of hyperpigmented skin conditions such as melasma or freckles.

Therapeutic areas: DermatologyWomen's Health
Modalities: Topical formulations (creams, gels, lotions)cosmetics
Industry: Biotech

Beyond the preview

Go deeper on Dermofarm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermofarm.

Explore the full profile